Literature DB >> 18563310

B-type natriuretic peptide levels in patients with COPD and normal right ventricular function.

Gökmen Gemici1, Refik Erdim, Aydin Celiker, Sena Tokay, Tunc Ones, Sabahat Inanir, Ahmet Oktay.   

Abstract

INTRODUCTION: Evidence suggests that elevated plasma levels of B-type natriuretic peptide (BNP) are found in patients with chronic obstructive pulmonary disease (COPD) and right ventricular dysfunction. We examined the effects of exercise on plasma BNP levels in patients with COPD who have normal right ventricular function
METHODS: Seventeen patients with a diagnosis of COPD and normal right ventricular function demonstrated by radionuclide ventriculography, and 17 age-and sex-matched healthy subjects underwent a treadmill exercise test. Plasma BNP levels were measured sequentially before, immediately after, and 1 hour after the exercise test
RESULTS: The mean plasma BNP+/-standard deviation levels of the COPD and control groups before exercise were 21.3+/-16 pg/ml and 13.4+/-11 pg/ml, respectively (P>0.05). Mean plasma BNP level measured immediately after exercise was 37.9+/-31 pg/ml in the COPD group, reflecting a statistically significant increase when compared with the initial value (P<0.05). The control group did not show any significant change in plasma BNP levels after the exercise test
CONCLUSIONS: Exercise induces an increase in plasma BNP levels in patients with COPD who do not have right ventricular dysfunction at rest. Measurement of exercise-induced BNP levels may be a useful alternative to pulmonary artery catheterisation in identifying the patients who are likely to benefit from long-term oxygen therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563310     DOI: 10.1007/s12325-008-0067-1

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  5 in total

1.  Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.

Authors:  Maria G Matera; Luigino Calzetta; Daniela Passeri; Francesco Facciolo; Erino A Rendina; Clive Page; Mario Cazzola; Augusto Orlandi
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 2.  B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.

Authors:  Nathaniel M Hawkins; Amit Khosla; Sean A Virani; John J V McMurray; J Mark FitzGerald
Journal:  BMC Pulm Med       Date:  2017-01-10       Impact factor: 3.317

3.  Plasma amino-terminal pro B-type natriuretic peptide as a predictor of late cardiovascular mortality in patients with acute lung disorders: a prospective, observational cohort study.

Authors:  Heikki O Koskela; Päivi H Salonen; Jarkko Romppanen; Juha Hartikainen
Journal:  ESC Heart Fail       Date:  2015-04-27

Review 4.  Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.

Authors:  Soma Jyothula; Zeenat Safdar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-24

5.  NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.

Authors:  Arne Didrik Høiseth; Torbjørn Omland; Tor-Arne Hagve; Pål H Brekke; Vidar Søyseth
Journal:  Respir Res       Date:  2012-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.